Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $0.75 | Change: +$0.03 | %Change: +4.17%
Volume: 13,300 | Day High/Low: 0.75/0.73 | 52 Week High/Low: 0.89/0.435

Snapshot

Last Traded: September 17, 2014 11:58 Transaction Volume: 13,300
Open: $0.75 Previous Close: $0.72
Bid: $0.73 Ask: $0.75
Bid Size: 2,500 Ask Size: 11,500
Market Cap: $64.0m Shares Out: 85.3m
PE Ratio: 2.5 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Blogger says 2014 may be a good year for Canadian Zinc (T.CZN)

Stockhouse Editorial   December 24, 2013
0 stars

Stockhouse Research: Sometimes no news is good news

Another day, another bullboard war. But not much else.

Chris Parry   September 10, 2013
0 stars

Stockhouse Research: The day Niko Resources came to play

Another day, another surprising block of Stockhouse user data.

Chris Parry   September 6, 2013
0 stars

Stockhouse Research: Resverlogix (T.RVX) and Colabor (T.GCL) sparking interest

Newcomers make the list on Stockhouse Research's roundup of what's hot on Stockhouse.com today.

Chris Parry   September 3, 2013
0 stars

Latest Bullboard Posts